Bromocriptine in severe cyclical breast pain

Abstract
The use of bromocriptine has been evaluated in a double-blind crossover trial of placebo against 5 mg bromocriptine over six menstrual cycles in 38 women with severe cyclical breast pain. Assessment using both the linear analogue system and clinical examination showed a statistically significant reduction in pain, tenderness and nodularity.
Funding Information
  • Sandoz Products Ltd.